Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Pharmacokinetic Study of Imipenem-Relebactam in Critically Ill Patients With Augmented Renal Clearance

NCT04147221 is registered in ClinicalTrials.gov with Hartford Hospital as lead sponsor.

NCT NCT04147221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04147221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Pharmacokinetic Study of Imipenem-Relebactam in Critically Ill Patients With Augmented Renal Clearance
Lead sponsor
Hartford Hospital
Phase
Phase 1
Overall status
Completed
Start date
February 10, 2020
Completion date
September 19, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis